Plasma Therapy Market Forecast: Breaking Down The Numbers Behind Future Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Plasma Therapy Market Size And Revenue Outlook Through 2030#_x000D_
The plasma therapy market has experienced rapid expansion in recent years. Its size is expected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.6%. The historical period’s growth can be linked to factors such as limited understanding of plasma therapy’s advantages, a reliance on traditional treatments, an uptick in orthopedic and sports medicine procedures, the development of hospital and clinic infrastructure, and the early incorporation of PRP in cosmetic applications._x000D_
_x000D_
The plasma therapy market is projected to experience substantial expansion in the coming years. It is set to reach $1.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the creation of sophisticated PRP and PRF formulations, an increase in regenerative medicine research, the broader application of plasma therapy in treating chronic and cardiac injuries, its growing use in dermatology and dental care, and the proliferation of clinical trials and research institutions. Key trends for the forecast duration encompass the increasing acceptance of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, the broadening scope of regenerative medicine and orthopedic applications, greater utilization in dermatology, hair restoration, and plastic surgery, a surge in demand for injectable and membrane-based fibrin items, and the incorporation of research and clinical trials to achieve better therapeutic results._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Plasma Therapy Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The increasing incidence of osteoarthritis is projected to stimulate growth in the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a specific kind of plasma therapy, is acknowledged as a safe and effective therapeutic option for osteoarthritis. As a concentrated autologous blood growth factor, Platelet-rich plasma (PRP) is injected into the joint, offering symptomatic relief by diminishing inflammation and decelerating the progression of osteoarthritis. For instance, data from September 2023, published by the Journal of Elsevier, a Netherlands-based publishing company, forecasts that by 2050, the global rise in osteoarthritis cases is anticipated to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other types of osteoarthritis. Common treatments currently utilized for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Therefore, the expanding prevalence of osteoarthritis is expected to be a key driver for the plasma therapy market._x000D_
_x000D_
#Plasma Therapy Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The plasma therapy market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF) _x000D_
2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications _x000D_
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Pure PRP: High Concentration PRP, Low Concentration PRP_x000D_
2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors_x000D_
3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF_x000D_
4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes_x000D_
_x000D_
#Plasma Therapy Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Key players in the plasma therapy market are bringing innovative products, such as the ESG-410, to meet evolving demands and enhance treatment alternatives. The ESG-410 is an Electrosurgical Generator specifically developed to deliver versatile options and improved efficiency in managing NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For illustration, in June 2023, Olympus Corporation, a medical technology company based in Japan, introduced its next-generation electrosurgical generator, the ESG-410. This device is utilized for treating bladder cancer and an enlarged prostate. The ESG-410 incorporates advanced design features, including enhanced capacitors, to ensure superior plasma stability during ignition. It offers rapid ignition and optimized plasma stability, marking an improvement over the ESG-400, particularly when employed with different loop sizes and oval buttons. The ESG-410 Electrosurgical Generator provides advanced treatment solutions for NMIBC and BPH by supplying a variety of resection loops, electrodes, and vaporization tools._x000D_
_x000D_
#Plasma Therapy Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc. _x000D_
_x000D_
#View The Full Plasma Therapy Market Report:#_x000D_
_x000D_
#Plasma Therapy Market Top Region By Revenue And Market Share#_x000D_
North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
